Clinical Trial Update: Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating oral elagolix tablets in combination with combined oral contraceptive capsules for dysmenorrhea in adults with endometriosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Combined Oral Contraceptive Capsule
• Orilissa (elagolix)

Snippet

Sponsor: AbbVie | Conditions: Endometriosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING